Exome Sequencing in stages of Treatment REsistance to Antidepressants

Project Information

ESTREA

Grant agreement ID: 793526

DOI

10.3030/793526

Project closed

EC signature date 23 March 2018

Start date 1 October 2018

End date 31 March 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 137 591,10

EU contribution

€ 137 591,10

Coordinated by

KING'S COLLEGE LONDON
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping

Author(s): Chiara Fabbri, Siegfried Kasper, Alexander Kautzky, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Rudolf Uher, Cathryn M. Lewis, Alessandro Serretti
Published in: Translational Psychiatry, Issue 10/1, 2020, ISSN 2158-3188
Publisher: Nature Publishing Group
DOI: 10.1038/s41398-020-0738-5

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment

Author(s): Chiara Fabbri, Stuart Montgomery, Cathryn M. Lewis, Alessandro Serretti
Published in: International Clinical Psychopharmacology, Issue ahead of print, 2020, ISSN 0268-1315
Publisher: Lippincott Williams & Wilkins Ltd.

Other (1)

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

Author(s): Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti, Cathryn M Lewis
Published in: MedRxiv, Issue online preprint, 2020
Publisher: MedRxiv
DOI: 10.1101/2020.03.31.20048538